Home / Going-concern warnings / Transcode Therapeutics, Inc.
Filed 2026-04-15 路 Form 10-K 路 Accession 0001104659-26-043810 nano
Price before filing: $8.9 (2026-04-14 close, split/dividend-adjusted)
Market cap at flag: $8.2M (2026-04-15) 路 Latest: $1.6M (2026-10-16)
| Window | RNAZ | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -25.8% | +6.4% | -32.3% | 2026-05-15 |
| 90 days | -3.6% | +8.5% | -12.1% | 2026-07-14 |
| 180 days | -81.7% | +12.6% | -94.3% | 2026-10-12 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"As discussed in Note 1 to the consolidated financial statements, the Company has suffered recurring losses from operations, has experienced cash used from operations, and has an accumulated deficit, that raise substantial doubt about its ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Going-concern opinion issued by: WithumSmith+Brown, PC
Source: independent auditor report in Form 10-K (period 2025-12-31)
Why this score: in auditor's report
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.